347 related articles for article (PubMed ID: 31448243)
1. Lycorine Derivative LY-55 Inhibits EV71 and CVA16 Replication Through Downregulating Autophagy.
Wang H; Guo T; Yang Y; Yu L; Pan X; Li Y
Front Cell Infect Microbiol; 2019; 9():277. PubMed ID: 31448243
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizic acid as the antiviral component of Glycyrrhiza uralensis Fisch. against coxsackievirus A16 and enterovirus 71 of hand foot and mouth disease.
Wang J; Chen X; Wang W; Zhang Y; Yang Z; Jin Y; Ge HM; Li E; Yang G
J Ethnopharmacol; 2013 May; 147(1):114-21. PubMed ID: 23454684
[TBL] [Abstract][Full Text] [Related]
3.
Meng T; Jia Q; Wong SM; Chua KB
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167919
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of enterovirus 71 replication by an α-hydroxy-nitrile derivative NK-1.9k.
Wang Y; Cao L; Zhai Y; Ma J; Nie Q; Li T; Yin Z; Sun Y; Shang L
Antiviral Res; 2017 May; 141():91-100. PubMed ID: 28063993
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice.
Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C
Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672
[TBL] [Abstract][Full Text] [Related]
6. Structures of Coxsackievirus A16 Capsids with Native Antigenicity: Implications for Particle Expansion, Receptor Binding, and Immunogenicity.
Ren J; Wang X; Zhu L; Hu Z; Gao Q; Yang P; Li X; Wang J; Shen X; Fry EE; Rao Z; Stuart DI
J Virol; 2015 Oct; 89(20):10500-11. PubMed ID: 26269176
[TBL] [Abstract][Full Text] [Related]
7. Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication.
Liu J; Yang Y; Xu Y; Ma C; Qin C; Zhang L
Virol J; 2011 Oct; 8():483. PubMed ID: 22029605
[TBL] [Abstract][Full Text] [Related]
8. Studies on Inhibition of Proliferation of Enterovirus-71 by Compound YZ-LY-0.
Yang Q; Jie Q; Shaw N; Li L; Rao Z; Yin Z; Lou Z
Int J Biol Sci; 2015; 11(11):1337-47. PubMed ID: 26640412
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of enterovirus 71 by adenosine analog NITD008.
Deng CL; Yeo H; Ye HQ; Liu SQ; Shang BD; Gong P; Alonso S; Shi PY; Zhang B
J Virol; 2014 Oct; 88(20):11915-23. PubMed ID: 25100827
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice.
Caine EA; Fuchs J; Das SC; Partidos CD; Osorio JE
Viruses; 2015 Nov; 7(11):5919-32. PubMed ID: 26593938
[TBL] [Abstract][Full Text] [Related]
11.
Caine EA; Osorio JE
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974562
[TBL] [Abstract][Full Text] [Related]
12. Antiviral screen identifies EV71 inhibitors and reveals camptothecin-target, DNA topoisomerase 1 as a novel EV71 host factor.
Wu KX; Chu JJ
Antiviral Res; 2017 Jul; 143():122-133. PubMed ID: 28427827
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolidine dithiocarbamate inhibits enterovirus 71 replication by down-regulating ubiquitin-proteasome system.
Lin L; Qin Y; Wu H; Chen Y; Wu S; Si X; Wang H; Wang T; Zhong X; Zhai X; Tong L; Pan B; Zhang F; Zhong Z; Wang Y; Zhao W
Virus Res; 2015 Jan; 195():207-16. PubMed ID: 25456405
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity.
Wang H; Zhong M; Li Y; Li K; Wu S; Guo T; Cen S; Jiang J; Li Z; Li Y
Antiviral Res; 2019 May; 165():23-33. PubMed ID: 30862444
[TBL] [Abstract][Full Text] [Related]
15. Salvianolic Acid B Inhibits Hand-Foot-Mouth Disease Enterovirus 71 Replication through Enhancement of AKT Signaling Pathway.
Kim SH; Lee J; Jung YL; Hong A; Nam SJ; Lim BK
J Microbiol Biotechnol; 2020 Jan; 30(1):38-43. PubMed ID: 31752055
[TBL] [Abstract][Full Text] [Related]
16. Rheum emodin inhibits enterovirus 71 viral replication and affects the host cell cycle environment.
Zhong T; Zhang LY; Wang ZY; Wang Y; Song FM; Zhang YH; Yu JH
Acta Pharmacol Sin; 2017 Mar; 38(3):392-401. PubMed ID: 27840410
[TBL] [Abstract][Full Text] [Related]
17. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease.
Lyu K; He YL; Li HY; Chen R
J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050
[TBL] [Abstract][Full Text] [Related]
18. Licochalcone A inhibits enterovirus A71 replication in vitro and in vivo.
Cao Y; Lei E; Wang X; Qi X; Li L; Ren J; Yang J; Wang S
Antiviral Res; 2021 Nov; 195():105091. PubMed ID: 34044060
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
20. Identification of luteolin as enterovirus 71 and coxsackievirus A16 inhibitors through reporter viruses and cell viability-based screening.
Xu L; Su W; Jin J; Chen J; Li X; Zhang X; Sun M; Sun S; Fan P; An D; Zhang H; Zhang X; Kong W; Ma T; Jiang C
Viruses; 2014 Jul; 6(7):2778-95. PubMed ID: 25036464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
